Leveraging the IDN Dataset: Your Essential Tool for 2025

Article

Leveraging the IDN Dataset: Your Essential Tool for 2025

January 28, 2025
Authors
Topics

As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.

Leveraging the IDN Dataset: Your Essential Tool for 2025

As 2025 gets underway, reconnecting with key accounts is top of mind for many. For oncology drug manufacturers, having the right tools to navigate these conversations is critical. That’s where our Integrated Delivery Network (IDN) Dataset comes in, providing the insights and clarity you need to drive meaningful engagement with 147 unique IDNs.

What Makes the IDN Dataset Stand Out?

The dataset includes comprehensive demographic and process data tailored to help you better understand and connect with IDNs, including:

  • 52 NCI cancer centers
  • 29 NCCN members
  • 96 academic health systems

This online dashboard enables you to anticipate and address the needs of IDN stakeholders effectively.

Leveraging the IDN Dataset: Your Essential Tool for 2025

Key Features at Your Fingertips

Our IDN-at-a-Glance Dashboard, accessible via our online portal, simplifies preparation for account teams by offering:

  • Quick Demographics Access: From the number of hospitals and oncologists to 340B eligibility and oral dispensing capabilities, key data are easily available.
  • Drug Assessment Insights: Understand P&T committees, evaluation criteria, and oncology subcommittees to streamline your engagement strategy.
  • Tailored Support for Stakeholder Needs: Provide the right data, such as trial data and total cost of care information, to match IDN-specific priorities.
  • Drug Management Overview: Quickly identify controls like order sets and pathways that influence treatment prescribing.

Now Available in Snowflake

We’ve enhanced accessibility by making our dataset available in Snowflake.

Looking Ahead

As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.  

Have questions? Reach out to our team or learn more about the portal with our IDN dataset overview! Send me a note at ebijesse@hmpglobal.com.  


Additional Resources

The Latest

Thought Leadership Whitepaper: How Will Medicare Drug Price Negotiations Really Impact Providers?
Article
Thought Leadership Whitepaper: How Will Medicare Drug Price Negotiations Really Impact Providers?

As manufacturers prepare for Medicare drug price negotiations, a critical question emerges: How will your provider engagement strategy evolve when Maximum Fair Prices (MFP) take effect in 2026?

Emma Bijesse
Meet Cindy: Data Integrity Expert and Pastry Connoisseur
Article
Meet Cindy: Data Integrity Expert and Pastry Connoisseur

One of Cindy’s favorite parts of working at HMP Market Access Insights is being part of a small, close-knit team. Collaborating with colleagues from different backgrounds has helped her expand her framework for viewing research.

Cindy Chen
Meet Chris: Payer Oncology Expert and Insight Sleuth
Article
Meet Chris: Payer Oncology Expert and Insight Sleuth

Chris passionately dig deeply into research to uncover nuggets of information that can make a real difference. His favorite part of the job? Interacting with clients and helping them view challenges through a fresh lens.

Chris Van Denburg